Reovirus serotype 1/strain Lang-stimulated activation of antigen-specific T lymphocytes in Peyer's patches and distal gut-mucosal sites: activation status and cytotoxic mechanisms

被引:7
作者
Bharhani, MS [1 ]
Grewal, JS [1 ]
Pilgrim, MJ [1 ]
Enocksen, C [1 ]
Peppler, R [1 ]
London, L [1 ]
London, SD [1 ]
机构
[1] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA
关键词
D O I
10.4049/jimmunol.174.6.3580
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intraduodenal priming of mice with reovirus serotype 1/strain Lang (reovirus 1/L) stimulates gut lymphocytes and generates precursor and effector CTLs. Our earlier studies demonstrated that germinal center and T cell Ag (GCT) is a marker which identifies reovirus 1/L-specific precursor CTL and effector CTL in Peyer's patches (PP) of reovirus I/L-inoculated mice. In this study, we characterized the expression of the activation markers, GCT and CD11c, on reovirus 1/L-stimulated gut lymphocytes and the effector mechanisms involved in reovirus 1/L-specific cytotoxicity. We found that intraduodenal reovirus 1/L inoculation of mice induced the expression of both GCT and CD11c on PP lymphocytes (PPL), intraepithelial lymphocytes (IEL), and lamina propria lymphocytes (LPL), and these activated cells expressed Fas ligand (FasL). The majority of the GCT(+)CD11c(+) IEL and LPL expressed a phenotype, TCRabeta(+)Thy-l(+)CD8(+) similar to that expressed on reovirus 1/L-stimulated PPL. However, splentic lymphocytes expressed GCT but not CD11c after stimulation with reovirus 1/L. Perforin, Fas-FasL, and TRAIL pathways were found to be involved in PPL, IEL, and LPL cytotoxic activity against reovirus 1/L-infected targets. In PPL, perforin. and Fas-FasL pathways were more effective than TRAIL. In IEL, all three cytotoxic mechanisms were equally as effective. However, LPL prefer Fas-FasL and TRAIL over perforin. Further, we demonstrated the preferential migration of GCT(+) PPL to the intraepithelial compartment and the lamina propria. These results suggest that GCT and CD11c can be used as activation markers for gut lymphocytes and CD11c can also be used to differentiate between activated gut and systemic lymphocytes. The Journal of Immunology, 2005, 174: 3580-3589.
引用
收藏
页码:3580 / 3589
页数:10
相关论文
共 32 条
[1]   DEVELOPMENTAL RELATIONSHIP BETWEEN CYTOTOXIC ALPHA/BETA T-CELL RECEPTOR-POSITIVE INTRAEPITHELIAL LYMPHOCYTES AND PEYER PATCH LYMPHOCYTES [J].
CUFF, CF ;
CEBRA, CK ;
RUBIN, DH ;
CEBRA, JJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) :1333-1339
[2]   T-helper 1 and T-helper 2 cytokine responses in gut-associated lymphoid tissue following enteric reovirus infection [J].
Fan, JY ;
Boyce, CS ;
Cuff, CF .
CELLULAR IMMUNOLOGY, 1998, 188 (01) :55-63
[3]   REOVIRUS-INDUCED LIVER-DISEASE IN SEVERE COMBINED IMMUNODEFICIENT (SCID) MICE - A MODEL FOR THE STUDY OF VIRAL-INFECTION, PATHOGENESIS, AND CLEARANCE [J].
GEORGE, A ;
KOST, SI ;
WITZLEBEN, CL ;
CEBRA, JJ ;
RUBIN, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :929-934
[4]   TRAIL: a molecule with multiple receptors and control mechanisms [J].
Griffith, TS ;
Lynch, DH .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :559-563
[5]   MOUSE GUT T-LYMPHOCYTE - NOVEL TYPE OF T-CELL NATURE, ORIGIN, AND TRAFFIC IN MICE IN NORMAL AND GRAFT VERSUS HOST CONDITIONS [J].
GUYGRAND, D ;
GRISCELLI, C ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (06) :1661-1667
[6]   2 GUT INTRAEPITHELIAL CD8+ LYMPHOCYTE POPULATIONS WITH DIFFERENT T-CELL RECEPTORS - A ROLE FOR THE GUT EPITHELIUM IN T-CELL DIFFERENTIATION [J].
GUYGRAND, D ;
CERFBENSUSSAN, N ;
MALISSEN, B ;
MALASSISSERIS, M ;
BRIOTTET, C ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02) :471-481
[7]  
HULEATT JW, 1995, J IMMUNOL, V154, P5684
[8]   THE GASTROINTESTINAL MUCOSAL IMMUNE-SYSTEM [J].
JAMES, SP .
DIGESTIVE DISEASES, 1993, 11 (03) :146-156
[9]  
Kim SK, 1999, J IMMUNOL, V163, P4125
[10]   Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas [J].
Koornstra, JJ ;
Kleibeuker, JH ;
van Geelen, CMM ;
Rijcken, FEM ;
Hollema, H ;
de Vries, EGE ;
de Jong, S .
JOURNAL OF PATHOLOGY, 2003, 200 (03) :327-335